Cargando…

Multiple drugs: COVID-19 pneumonia secondary to hypogammaglobulinaemia and off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732204/ http://dx.doi.org/10.1007/s40278-022-08127-2

Ejemplares similares

Multiple drugs: Prolonged course of COVID 19 infection and hypogammaglobulinaemia: case report
Publicado: (2022)

Rituximab: Hypogammaglobulinaemia and recurrent COVID-19 infection: case report
Publicado: (2022)

Tisagenlecleucel: Hypogammaglobulinaemia and pancytopenia: case report
Publicado: (2021)

Rituximab: Hypogammaglobulinaemia: 2 case reports
Publicado: (2021)

Bendamustine/obinutuzumab: COVID-19 disease, pancytopenia and hypogammaglobulinaemia: case report
Publicado: (2021)

Multiple drugs: Lack of efficacy in COVID-19 pneumonia and off label use: case report
Publicado: (2021)

Multiple drugs: COVID-19 pneumonia, off-label use and lack of efficacy: case report
Publicado: (2021)

Multiple drugs: Hypoglycaemia secondary to off-label use: case report
Publicado: (2020)

Recurrent COVID‐19 infection in a case of rituximab‐induced hypogammaglobulinaemia
por: Daniel, Jefferson, et al.
Publicado: (2021)

Multiple drugs: COVID-19-pneumonia, off-label use and lack of efficacy: 2 case reports
Publicado: (2021)

Multiple drugs: Pancytopenia, COVID-19 and off-label use: case report
Publicado: (2020)

Multiple drugs: COVID-19 and off-label use: 2 case reports
Publicado: (2020)

Multiple drugs: COVID-19 infection and off-label use: case report
Publicado: (2021)

Multiple drugs: COVID-19 and off-label use: 22 case reports
Publicado: (2021)

Case report of Ureaplasma urealyticum meningitis in a patient with thymoma and hypogammaglobulinaemia
por: Zhang, Ting, et al.
Publicado: (2021)

Bendamustine/remdesivir/rituximab: Lymphocytopenia, hypogammaglobulinaemia and rebound viral shedding following drug resistance: case report
Publicado: (2022)

Multiple drugs: Off-label use and failure to respond in COVID-19: case report
Publicado: (2022)

Multiple drugs: Pneumocystis jirovecii pneumonia following off label use and hypersensitivity: case report
Publicado: (2022)

Multiple drugs: Protracted severe COVID-19 pneumonia, hepatotoxicity and lack of efficacy following off label use: case report
Publicado: (2022)

Multiple drugs: COVID-19 infection, drug induced psychosis and off-label use: case report
Publicado: (2021)

Multiple drugs: Development of acute kidney injury secondary to drug-interaction and off-label use: case report
Publicado: (2021)

Multiple drugs: Drugs ineffective and off-label use: case report
Publicado: (2022)

Multiple drugs: COVID-19 infection, lack of efficacy and off-label use: case report
Publicado: (2021)

Multiple drugs: Off label use, pulmonary aspergillosis and COVID-19 pneumonitis: case report
Publicado: (2021)

Multiple drugs: Lymphocytopenia and off-label use: case report
Publicado: (2020)

Multiple drugs: Bradycardia and off-label use: case report
Publicado: (2021)

Multiple drugs: No response and off label use: case report
Publicado: (2021)

Multiple drugs: No response and off-label use: case report
Publicado: (2021)

Multiple drugs: Infections and off label use: case report
Publicado: (2021)

Multiple drugs: No improvement and off label use: case report
Publicado: (2022)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Dementia in a patient with Thymoma and hypogammaglobulinaemia (Good's syndrome)
por: de Jesus, Nelson Pedro Ferreira, et al.
Publicado: (2008)

Thymoma associated with hypogammaglobulinaemia and pure red cell aplasia
por: Briones, Juan, et al.
Publicado: (2013)

Cladribine/hydroxychloroquine: COVID-19-pneumonia, lymphopenia and off label use: case report
Publicado: (2020)

Multiple drugs: Carbapenem-resistant Klebsiella pneumoniae infection due to off-label use: 9 case reports
Publicado: (2021)

Multiple drugs: COVID-19, acute kidney injury and off label use: 2 case reports
Publicado: (2020)

Multiple drugs: COVID-19, and treatment failure following off-label use: 2 case reports
Publicado: (2021)

Multiple drugs: COVID-19 infection, renal allograft infarction and off-label use: case report
Publicado: (2021)

Multiple drugs: Recurrence of COVID-19 infection, off-label use and lack of efficacy: case report
Publicado: (2022)

Correlation of hypogammaglobulinaemia with proteinuria, and the relationship between hypogammaglobulinaemia and infection in active lupus nephritis
por: Smilek, Dawn Elaine, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sba32bk410slokdv6p0nbpbv2b